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Abstract
Background: Despite a large evidence-base upon which to base clinical practice, most health systems have not
combined the training of healthcare providers in addiction medicine and research. As such, addiction care is often
lacking, or not based on evidence or best practices. We undertook a qualitative study to assess the experiences of
physicians who completed a clinician-scientist training programme in addiction medicine within a hospital setting.
Methods: We interviewed physicians from the St. Paul’s Hospital Goldcorp Addiction Medicine Fellowship and
learners from the hospital’s academic Addiction Medicine Consult Team in Vancouver, Canada (N = 26). They
included psychiatrists, internal medicine and family medicine physicians, faculty, mentors, medical students and
residents. All received both addiction medicine and research training. Drawing on Kirkpatrick’s model of evaluating
training programmes, we analysed the interviews thematically using qualitative data analysis software (Nvivo 10).
Results: We identified five themes relating to learning experience that were influential: (i) attitude, (ii) knowledge,
(iii) skill, (iv) behaviour and (v) patient outcome. The presence of a supportive learning environment, flexibility in
time lines, highly structured rotations, and clear guidance regarding development of research products facilitated
clinician-scientist training. Competing priorities, including clinical and family responsibilities, hindered training.
Conclusions: Combined training in addiction medicine and research is feasible and acceptable for current
doctors and physicians in training. However, there are important barriers to overcome and improved
understanding of the experience of addiction physicians in the clinician-scientist track is required to
improve curricula and research productivity.
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Background
Socio-structural factors continue to drive problematic
drug use and related harms. A lack of physician training
in addiction medicine partially shapes the barriers to
proper care and treatment for people who use drugs
(PWUD). Although it has been argued that there has
been too much focus on information provision as a
route toward behaviour change, addressing deficits in
physician training represents an opportunity to employ
educational approaches to improve health of PWUD.
Advances in addiction science have helped to identify
effective treatments, in particular early identification and
treatment of substance-related disorders [21]. Unfortu-
nately, these treatments are under-utilized by physicians,
in part due to a lack of knowledge and accredited
training programmes in addiction medicine [34, 47].
Among the few programmes recognised internation-
ally is the Dutch two-year Master in Addiction Medicine
(MiAM) integrates clinical-practice learning with theory
on evidence-based medicine, communication and basic
psychotherapeutic skills, neurobiology of addiction,
addiction medicine, addiction and psychiatry, and public
health, thus shaping seven core competencies of future
addiction professionals [9]. Similarly, Norway has
created a full medical specialty in addiction medicine in
response to the government’s mandate from 2010. The
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first cohort was trained in Autumn 2014 [20]. The new
Australian training scheme, modelled on the internal
medicine training programme, offers three years of
discipline-specific supervised training with continuous
assessment and broad focus on harm reduction and
evidence-based treatment [18]. Given the scarcity of
existing training programmes, evaluation research is
warranted to better understand experience of learners in
these programmes and guide future training efforts.
Clinician-scientists bridge the gap between addiction
research and clinical practice. Their capacity to translate
research into practice is greater given their understand-
ing of human disease and people, as both patients and
as research subjects [5]. Non-researcher clinicians and
non-clinician researchers do not have this advantage
[30]. To this end, the literature has demonstrated how
low rates of research training among physicians (in areas
other than addiction) are attributable to a range of fac-
tors including debt associated with medical education
and inflexible educational programmes [10, 19, 41, 51].
Concerns persist about the feasibility of combining
clinical and research training in addiction medicine.
Combined training is impeded by the inflexibility of
standard training programmes, as well as the lack of
hands-on experience, mentors, career counselling and
supportive training environments [3, 43, 48, 49]. Fur-
thermore, established physicians often do not receive
formal recognition for additional research training and
face competing clinical priorities stemming from patient
care [19, 29, 49].
Recently, the St. Paul’s Hospital Goldcorp Addiction
Medicine Fellowship [53], and a Research Fellowship in
addiction medicine funded by the U.S. National Institute
of Drug Abuse, have been established in Vancouver,
Canada, to address these challenges [40]. These fellow-
ships provide support from researchers, statisticians, and
the hospital Addiction Medicine Consult Team to fellows,
medical students and residents on rotations to facilitate
research training and experience. This type of learning
environment is rare, and examination of learners’ experi-
ences is merited. Knowledge of their experiences would
help us better understand their needs and tailor educa-
tional programmes accordingly. We conducted a qualita-
tive study of learners’ experiences of combined clinical
and research training in addiction medicine.
Methods
Qualitative interviews were conducted to examine the
experiences of combined clinician-scientist training in
addiction medicine through the two Fellowships.
Setting
The St. Paul’s Hospital Goldcorp Addiction Medicine
Fellowship and the Canada Addiction Medicine Research
Fellowship provide physicians who have completed foun-
dational clinical training in family medicine, psychiatry,
internal medicine, or other speciality with further training
in addiction medicine. While the focus of the clinical
fellowship is on direct patient care, both streams receive
research training. The core learning occurs within the
Addiction Medicine Consult Team (AMCT) at St. Paul’s
Hospital that provides inpatient Addiction Medicine con-
sultations [40]. Consultations involve addiction treatment
coordination for medical co-morbidities, opioid agonist
therapy initiation, continuation and monitoring, as well as
inpatient withdrawal and detoxification management, and
motivational interviewing. The team conducts all follow-
up treatment recommendations and coordination. Ad-
diction Medicine Fellows, medical students, residents and
enhanced skills learners are accepted for rotations. The
Fellows perform senior tasks and share team oversight
with the AMCT members. The team and the Principal
Investigator (PI) provide comprehensive research training.
Learners’ obtain data from Urban Health Research Initia-
tive’s (UHRI) cohort studies of HIV-negative injection
drug users, HIV-positive drug users, and street-involved
youth, described elsewhere [22, 46, 52], and receive statis-
tical support from statisticians to develop analyses for
publication [25].
Recruitment
Potential participants included all learners who had
completed the clinical fellowship, research fellowship or
enhanced skills training; the staff of the AMCT; and any
students or residents who have done a one-month rota-
tion and also prepared a research publication. Also the
teaching faculty for the fellowship (including nurses,
social workers and the fellowship director) were invited
to participate in the qualitative interviews to better
understand training processes and objectives. The partic-
ipants were invited via email by the principal investiga-
tor, followed by reminders from an assistant; 26 (84%) of
the 2013–15 cohort members participated.
Data collection
Interviews utilized a topic guide informed by a scoping
review of the literature and a previous qualitative study
on a similar topic with health professionals in Portland,
Oregon [27]. The topic guide made use of a series of
questions focused on the experience of learning, positive
and negative aspects of the training, and the training
environment. Interviews were audio-recorded and tran-
scribed verbatim. Interviews started with a journey plot-
ting exercise, which was used to capture the experience
of learning and related emotion over time [33]. At the
beginning of the interview, we asked participants to
draw a timeline of their training (five interviews were
done over phone, without journey plots). They marked
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significant events and corresponding high and low
points. The horizontal axis represented time and the
vertical axis described emotional experience. Journey
plots are well suited to capturing experiences and corre-
sponding emotions through time [33, 35]. We asked
interviewees to note the significant milestones in their
learning experiences and to comment on them. This
way, we collected empirical data regarding the learning
experience, as well as the related meaning or emotional
dimension. While the quantification of research product-
ivity via the number of published papers (i.e., track
record), is the most frequently used evaluation indicator,
it is limited and a richer, more complete evaluation of
the research-training process is needed [31]. An in-
depth understanding of the training process would help
us better tailor educational programmes to the specific
needs of learners [41, 49]. We chose a qualitative re-
search design because it can help uncover the meaning
and characteristics of learning experience not easily
captured with quantitative research approaches [36, 44].
Data analysis
Five steps guided a qualitative analysis of interview
transcripts: 1) data preparation, transcription and
familiarization, 2) generation of initial codes, 3) theme
assessment, 4) theme review, and 5) theme finalization
[4, 12]. Curran and Fleet’s adaptation of Kirkpatrick’s
model was used to conceptualise our analytical frame-
work in relation to four levels of evaluating training
programmes: 1) learner satisfaction, 2) learning outcomes
(i.e., skills, knowledge and attitudes), 3) performance im-
provement (i.e., behaviour) and 4) patient outcomes [8].
The first author generated themes based upon a priori
and emergent codes, and used qualitative data analysis
software (NVivo 10, www.qsrinternational.com) to code
transcript material. Two external reviewers examined
selected quotes, considering them against the themes. Our
analysis integrated the interview and the journey plot find-
ings. We looked for similarities and differences in the
journey-plot curves and grouped similar plots together.
We sought to understand the patterns in learning experi-
ences by identifying the tempo (how quickly learning
went) and the intensity (how significant the learning was)
of learning.
Results
Socio-demographic characteristics
Our participants included clinical fellows (n = 8), research
fellows (n = 4) or enhanced skills learners (n = 2), and all
students or residents who have done a one-month rota-
tion and also prepared a research report (n = 11); as well
as the staff of the AMCT and teaching faculty for the
fellowship (including nurse, social worker and fellowship
ex-director, n = 4). Participant numbers do not add up to
26 because some participants fell into several categories.
Their mean age was 33 years (range 25–53 years) and 14
were women.
Thematic analysis
Using Kirkpatrick’s conceptual model, thematic analysis
revealed five major themes relating to learning experi-
ence which were influential: (i) attitude, (ii) knowledge,
(iii) skill, (iv) behaviour and (v) patient outcome. The
presence of a supportive learning environment, flexibility
in time lines, highly structured rotations, and clear guid-
ance regarding manuscript development helped facilitate
clinician-scientist training. Competing priorities, includ-
ing clinical and family responsibilities, hindered training.
Attitude towards people with addictions
In line with the vision for the fellowship, trainees
reported acquiring better advocacy skills and more
empathic disposition as a product of the training:
I think I’ve learned more about advocacy, and because
I had the chance to spend a whole dedicated year to
like “addiction”. I had a chance to think about all the
socioeconomic factors, I went to all the different
rotations …I was, all the different people at different
points [in varying rotations].” [Participant #24,
Female, 30 years old]
The participants acted in multiple different roles
through the rotations. Improved empathy among trainees
was reported to be a product of interactions with indi-
vidual mentors, rather than a function of the training
programme itself:
“Cause it’s nice to get the letters [clinical designation],
but I think the main aim is to have compassionate
clinicians who treat people with addiction well.”
[Participant #12, Female, 34 years]
Longer clinical rotations similarly supported the de-
velopment of empathy among trainees, and some felt
empathy is in fact a characteristic that can be taught:
“I think often there’s a belief that you can’t teach
someone empathy but you really can, and I see that
in the residents who come for electives with me,
especially if they come for a long time.” [#12, Female,
34 years]
Improved knowledge of addiction science and addiction
treatment
Overall, the learners described how the fellowship
produced “heightened awareness” of addiction medicine,
and addressed the deficiencies in addiction-related
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education from their previous medical training. Addiction-
related education in medical school was largely perceived
as inadequate:
“I didn’t go to medical school here so I’m not sure
how it’s structured here but we definitely have clinical
skills and communications curricula that the cases
where you would have a respirology case, and a
cardiology case and a haematology case, and why
not have an addictions case weaved into that
[#16, Female, 27 years]
Further, trainees’ knowledge of the limited addiction-
specific coursework and content was not regularly tested
in standard training:
“they test, you know, 5% of the course. 95% is
untested- so it doesn’t encourage people to go to
it because they don’t really care too much.”
[#6, Male, 27 years]
As a product of the fellowship, participants recognised
addiction as a disease with all its social and medical di-
mensions, as well as the related public-health, harm-
reduction and evidence-based responses:
“I think the fellowship really was geared to teaching
the science behind addiction and the science behind
the management of addiction.” [#10, Female, 34 years]
Faculty had a similar perspective, reporting that train-
ing Fellows keeps mentors and teachers current regard-
ing best practices and treatments:
“being part of the clinical fellowship helps to really
keep you on your toes.” [#9, Female, 29 years]
Improving clinical skills
It was reported that clinical, research and generic skills
(i.e., communication, teamwork, etc.) improved due to
training received through the Fellowship. Clinically, par-
ticipants felt the training was highly beneficial, providing
extensive opportunities to interact with people who had
addictions issues:
“[it was] good because we saw a lot of very sick
patients, so just like learning how to diffuse situations,
and how to go around asking the information that
you need to know, and how to observe patients while
you’re talking to them.” [#17, Female, 25 years]
Overall, the high proportion of patients with addiction
issues present within the hospital environment where
training was provided was perceived to be conducive to
learning, but this could be challenging, at times.
While trainees sometimes experienced difficulties con-
ducting patient exams, interactions with people with
severe addictions provided opportunities to navigate
past these challenges:
“I think the clientele here definitely affects the type
of learning and then it’s hard to learn how to take
proper history and full physical examinations here,
as opposed to somewhere more remote. I find that
some of the patients are not as compliant, or not
as accepting of students, at times, and they
sometimes just hate medical students or doctors, in
general [laughter], so I mean that happens
everywhere, but I’ve had more incidents where a
patient would just be […] less accepting.” [#18,
Male, 26 years]
Improving research skills
Fellows reported that the flexibility, structure and clear
guidance provided within the Fellowship training facili-
tated the acquisition of research skills. In addition, the
mixture of guided and independent learning was seen to
be beneficial:
“so he [my mentor] let me pick an area that
interested me. He gave a lot of oversight at each
stage of the process, like developing the research
question, doing the data request, getting a sense of
how to interpret the stats, and then writing it up.
So, he was very involved at each stage of the way,
but I still somewhat independently gave it a shot
the first time around, and so it raised my
confidence.” [#25, Female, 32 years]
Similarly, autonomy in research training was seen to
be strength of the Fellowship:
“I think you’re provided with a lot of autonomy,
which I like.” [#10, Female, 34 years]
Competing priorities hindered clinician-scientist tra-
ining, particularly balancing research tasks with the
demands of clinical work and rotations:
“I find that a lot of people who are engaged in the
research process really like it. It’s their primary focus,
and so I often feel guilty for still really wanting to be
involved as a clinician. And so I kind of see it fifty: fifty
almost, but that’s really difficult to do.” [#10, Female,
34 years]
Achieving balance between clinical work and research
tasks was difficult:
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“It’s a tough balance, I think, between being a
clinician and trying to be a researcher at the same
time [#1, Male, 43 years]”.
Performance improvement: behaviour
The learners felt that they became better health profes-
sionals as a result of the experiences and training:
“when you step into the addiction medicine world, all
of a sudden even your relationship with your patients
changes a little bit, so I find that the way I behave and
my professional demeanour around my patients has
changed a bit throughout this year.” [#20, Male,
29 years]
Similarly, Faculty felt that participation, as a men-
tor, was also beneficial for their clinical practice the
same way:
“Yeah, I’m a better doctor because I’m a teacher at the
fellowship, I think.”[#12, Female, 34 years]
Performance improvement: patient outcome
Fewer participants reported pronounced changes but
their comments indicate recognition that flexibility re-
garding patients’ goals was paramount:
“These patients have very different needs than other
patients. You need to be a lot more flexible and I
think you have to; I guess it all just comes down to
re-prioritizing what you want your outcomes to be,
but [prioritizing] their out[comes]- what outcomes
they want.” [#21, Male, 27 years]
The Fellowship helped develop a patient-centred
focus. This focus became evident when the fellowship
changed from offering short-term rotations exclu-
sively, to include some long-term, rotations, e.g., fol-
lowing patients longitudinally. Initially, the fellows
reported that short rotations did not fully maximize
learning opportunities:
“I think we as a fellowship has been fairly universal in
our feedback about this rotation, that we didn’t get
enough longitudinal stuff in there.” [#15, Male,
35 years]
Findings of analysis of the journey plots
Within the 21 journey plots there was a general pattern
evident in approximately half of the learners’ journeys:
many highs and lows above and below the neutral point
with the final point high up (Fig. 1). Put simply, the jour-
ney was relatively high paced (speed of learning) and
high strength (emotional intensity of experiences):
“I felt there was a very steep learning curve and I had
very little background or knowledge in the area and
initially, I felt not overwhelmed, but I had a lot to
learn and then, as the year went on, that decreased as
I started to get more exposure and get more
comfortable with the patient population.” [#10,
Female, 34 years]
In contrast, seven participants drew a flat line indicat-
ing a smooth, relatively eventless learning, as illustrated
in the following quote of a person who was a learner
and subsequently has taught fellows:
“[…] it has been wonderful [training], I love teaching
the fellows, I love working with the fellows that have
graduated, it’s so collegial and pleasant.” [#12, Female,
34 years]
Five participants described a linear upward trend (with
slow pace) and very small dips (low strength) indicated
by 3–5 significant events:
“Clinically I feel like it was always just going up and
up and up and up. It was different than being a
resident in that I know now how to function within
the medical system so clinically I didn’t find it
difficult.”[#19, Female, 35 years]
For two participants, many ups and downs (relatively
slow pace) oscillating high and low around the neutral
point (low strength) and showing mild emotions were
illustrated by descriptions of many significant events:
“It was really a steep learning curve for me because
there was lots to do, and working as part of a team
[…] even though that was a good experience, it was a
hard experience- so maybe I draw the line kind of up
and down at that point for a little bit, almost like a
squiggly line.” [#22, Male, 33 years]
One participant experienced an unusually low pace; the
strength was high, with only one huge dip shortly after the
start, followed by an upward trend. He explained:
“it was around then [beginning of the training, points
to the dip in the journey plot] when things sort of
started to kind of fall apart a little bit. I think one of
the biggest road blocks was just getting the case
[study data] […] actually getting access to the case, to
the chart took [a very long time].” [#7, Male, 25 years]
While experiences like this were rare, it points to the
importance of support, supervision and monitoring in
addiction medicine education.
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Discussion
Analysis of qualitative interviews explored the experience
of training in addiction medicine and research. The pres-
ence of a supportive learning environment, flexibility in
time lines, structured rotations, and clear guidance re-
garding research product development helped facilitate
clinician-scientist training. Competing priorities, including
clinical and family responsibilities, hindered training. Our
findings yield further insight into the process of combin-
ing clinical and research training in addiction medicine,
and can be used to inform similar programs elsewhere.
That current and upcoming physicians held positive
attitudes towards the training was not surprising, given
their self-selection for the training and the study. It is
possible that doctors, who participate in specialised
training, already have some experience with addiction
research and appreciation for the field [45]. Although
literature confirmed that attitude and competency gain
takes longer to demonstrate, our participants reported
positive learning outcomes, such as increased knowledge
following the training [13]; however, it is unclear
whether combined clinical and research training made
them better doctors and whether patient outcomes
improved [37, 39]. Future evaluations of clinician-
scientist programmes should employ robust study de-
signs and strategies, with a focus on outcome analyses
[2, 11, 28]. The analyses should assess the impact
upon provider behaviour and patient outcomes, as
per Kirkpatrick’s model [8].
The supportive learning environment of the Fellow-
ship and the short, structured research projects were
seen to be the most beneficial features of the training.
This is consistent with previous literature that described
a combined didactic and experiential learning approach
to clinical-scientist education in addiction [6, 11, 38].
Qualitative meta-syntheses concur with these results,
placing further emphasis on the role of mentoring [44].
Research regarding strategies to increase research prod-
uctivity among early-career investigators in the addic-
tions field is scarce [17]. Several formative experiences
influenced research productivity among participants in
our study. Some literature suggests a decline in learners’
productivity is common once they enter clinical service,
probably due to competing priorities and work-life bal-
ance [14, 42]. Our findings suggest that having to balance
one’s competing priorities as a physician, scientist, teacher,
parent or spouse can both hinder and foster research
productivity. The increasing demands limit the number of
projects that clinical-scientists can work on, but they force
them to make the best use of their time. Strategies, such
as mentorship, adequate reimbursement, and maintenance
of work-life balance can further support the development
of physicians as addiction clinician-scientists [23]. More
research is required to compare and contrast findings
from this training program to other training models, such
as the CRITS or the Substance Abuse Research Education
and Training (SARET) [26, 50]. While those models aimed
to increase trainees’ knowledge, skills and attitudes in
addiction medicine, or interest in research, our model
capitalized on the immersive learning method and expert-
ise of HIV scientists who mentored the next generation of
physician researchers and aimed to increase their product-
ivity. Our trainees also received stipends in addition to
their clinical salaries. We designed the programme to be
lecture-light and flexible.
Our interviewees suggested several improvements
for physician training in addiction research. They
unanimously agreed that the training should continue
Fig. 1 Sample journey plot depicting experience of a resident in the combined clinician-scientist training programme. This sample journey plot
depicts the experience of participant #3 during a first rotation as a senior resident. aDowns: “day in and day out and going to work, there are
certain you know certain times where you feel like you’re having a day off […] there are ups and downs with sometimes not be[−ing] able to
connect or establish a rapport with somebody”. bUps: “i do remember a lot of really nice moments; a lot of people who i think i was able to
help establish a nice plan for their addiction that would help them actually get out into the community, into a supported living environment
that required them to be on a certain kind of methadone, or a certain kind of treatment”
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in the future. This requires continued funding for the
programme. The programme should be scaled-up [24].
Indeed, the clinician-scientist “species” are thought to be
on the verge of extinction [23], and recently announced
funding cuts to MD/PhD programmes in Canada further
endanger the education of specialists and thus, threaten
efforts to improve care and treatment of people with
addictions [7]. Training the next generation of physicians
in addiction medicine and research can speed up the
development and uptake of new treatments [1]. In agree-
ment with previous qualitative research from other disci-
plines, “learning to account for the social determinants of
health” affecting marginalised population is key in this
type of training [16, 32]. Although clinician-scientist train-
ing alone won’t solve the addiction problem, it is the
Archimedean “one firm spot on which to stand,” and has
potential to advance the discovery of new therapies and
their translation into routine care.
Our research should be interpreted with caution. Our
sample was relatively small and comprised of residents,
students and staff from a single Canadian programme,
which may limit the transferability of our findings. Our
study evaluated the learning experiences of trainees at
one institution and their views may not necessarily relate
to trainees at other institutions, although they do hold
insight for other similar training programs. Our partici-
pants were not selected randomly, although we invited
everyone who was involved in the training and achieved
an excellent response rate. We achieved data saturation
as recommended for nonprobabilistic sample sizes [15].
It is probable that physicians who seek specialised train-
ing are more likely to have positive attitudes towards,
and more educational experience with, people who have
addiction issues [45]. We recognize that our learning
culture may be more fostering or conducive to pro-
moting research to trainees. Nevertheless, the area has
traditionally served as an environment where new drug-
related training policies and approaches are tested and,
if found effective, may be applied elsewhere. With the
movement to enhance addiction medicine training within
larger U.S. medical schools, future research should exam-
ine whether similar efforts to foster research within other
clinical training venues produce the same benefit. The
insight into experiences of a unique combination of
training in addiction medicine and research provided
by this qualitative analysis is valuable, and provides a
detailed and nuanced understanding of training trajec-
tories and experiences.
Conclusion
Combining clinical and research training in addiction
medicine is feasible and acceptable for current and
upcoming doctors; it is not easy, though. Most learners’
experience the training positively. We must understand
the experience of addiction physicians in the clinician-
scientist track if we want to improve curricula and
research productivity, as well as patient outcomes in
this field. Evaluation of track record in terms of
research productivity needs to be supplemented by an
experiential dimension.
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